NCT06083883 2026-04-16Phase I/Ib Study of NK Expressing an Affinity-enhanced T-cell Receptor (TCR) Against the NY-ESO-1M.D. Anderson Cancer CenterPhase 1 Recruiting44 enrolled
NCT05711615 2026-04-13Testing Low-Dose Common Chemotherapy (Liposomal Doxorubicin) in Combination With an Anti-Cancer Drug, Peposertib, in Advanced SarcomaNational Cancer Institute (NCI)Phase 1 Recruiting30 enrolled